Enzon Pharmaceuticals

NAS:ENZN

Biotechnology

Market Cap

—

MICRO cap

Share Price↑↓←

(—)

YTD Return ↑↓←

—

since start of 2022

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

BiotechnologyFounded 1981

Enzon Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in the provision of licensing arrangements. It also involve in selling marketed drug products namely: PegIntron, Sylatron, Macugen, and CIMZIA. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.

Headquarters

20 Commerce Drive

Suite 135

Cranford, NJ 07016

1.732.980.4500

Executives

Name	Title	Gender
Richard L. Feinstein, CPA	Chief Financial & Accounting Officer, VP-Finance	Male
Andrew D. Rackear	Chief Executive Officer & Secretary	Male
Abraham Abuchowski, PhD	Founder	Male
Jonathan Christodoro, MBA	Chairman	Male

Mindful Investing Summary

Carbon Footprint
—N/A
Enzon Pharmaceuticals among its competitors for its carbon footprint. A company’s performance in this category is based on its success in implementing energy efficiency measures. Investments in energy efficient technology, green building and sourcing of renewable energy can all lead to cost savings and reduce the company’s contribution to climate change.
Pollution Prevention
—N/A
Enzon Pharmaceuticals on this issue. Companies are evaluated on pollution prevention by the levels of waste (including hazardous waste) they produce and release into the environment, and can be affected by whether they develop products that can reduce exposure to pollution.
Water Conservation
—N/A
Enzon Pharmaceuticals among its peers in this category. A company’s score in this category depends on its measures to minimize water usage and impacts on stressed or drought-prone water resources.
Data & Privacy Protection
—N/A
Enzon Pharmaceuticals among its peers and competitors for data privacy and protection. Companies today digitally manage vast amounts of personal information about their clients. A company’s score on this issue is based on the systems, products and procedures it has in place to minimize the risk for data and privacy breaches.
Consumer Health, Wellness & Safety
—N/A
Enzon Pharmaceuticals compared to its peers and competitors Companies in this category manage its product and safety risks.
Employee Ownership, Satisfaction, Benefits & Pay
—N/A
Enzon Pharmaceuticals among its peers for employee satisfaction and pay. A company’s score on this issue depends on its frequency and likelihood of labor disputes as well as its practices to keep and retain talent - such as compensation, family leave, employee health care and other benefits. Employers that are rated as good to work for consistently produce higher stock returns than their peers.
Workplace Health and Safety
—N/A
Enzon Pharmaceuticals among its competitors on this issue. A company’s workplace health and safety is evaluated not only by the number of accidents and injuries in the workplace, but also by their safety policies, training procedures, and their investment in equipment that can reduce accidents.
Integrity of Corporate Governance
—N/A
Enzon Pharmaceuticals among its competitors on corporate governance. This score is determined by the company’s accounting practices, executive pay, board organization and ownership structure.
Ethical Practices
—N/A
Enzon Pharmaceuticals compared to its peers and competitors. A company’s rating on this issue is based on its history of controversies related to unethical corporate behavior, such as false claims about their products, price fixing, executive misconduct, insider trading or fraudulent practices.
Usage of Conflict Materials
—N/A
Enzon Pharmaceuticals among its competitors in this category. Certain products use raw materials that are commonly sourced from militias or other organizations that promote or engage in conflict in their region. To perform well in this category companies must provide adequate assurances that any of these metals used in their production are in fact from conflict-free sources.
Forced Labor
—N/A
Enzon Pharmaceuticals compared to its competitors on forced labor. A company’s score on this issue depends on its use of forced labor and on its work conditions for outsourced labor.
Diversity of Corporate Leadership
—N/A
Enzon Pharmaceuticals based on its peers as well as companies in similar geographic regions. Companies are assessed on factors such as board diversity and senior management diversity. Companies performing well on this issue typically are more profitable than its peers, while companies with very poor scores typically have greater stock price volatility and lower returns on capital.

Enzon Pharmaceuticals - Competitors and Related Companies

How Enzon Pharmaceuticals stacks up to its peers in theBiotechnology industry or with competing business segments.